Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...
ASX tanks to a four-month low after Trump’s tariffs, oil spikes, crypto dips, and Novonix jumps on the back of a win in China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback